New blood test greatly reduces false-positives in prostate cancer screening
Friday, May 29, 2009 - 12:35
in Health & Medicine
A new blood test used in combination with a conventional prostate-specific antigen (PSA) screening sharply increases the accuracy of prostate cancer diagnosis, and could eliminate tens of thousands of unneeded, painful, and costly prostate biopsies annually, according to a study led by researchers at Dana-Farber Cancer Institute...
Read the whole article on Science Centric
More from Science Centric
Related
- New blood test greatly reduces false-positives in prostate cancer screeningThu, 28 May 2009, 11:46:01 EDT
- PSA screening may be biased against obese men, leading to more aggressive cancersFri, 8 Aug 2008, 6:14:59 EDT
- Routine evaluation of prostate size not as effective in cancer screening, Mayo study findsTue, 10 Nov 2009, 11:24:51 EST
- Monitoring blood flow helps improve prostate biopsies, Jefferson researchers reportSat, 24 May 2008, 16:28:31 EDT
- Overdiagnosis since introduction of prostate cancer screeningMon, 31 Aug 2009, 18:36:12 EDT